ARIAD PHARMACEUTICALS INC Earnings Per Share (Diluted)
ARIAD PHARMACEUTICALS INC reported Earnings Per Share (Diluted) of -$0.14 per share for the 3-month period ending 2016-09-30, per its 10-Q filed 2016-11-08.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2016-11-08
- ARIAD PHARMACEUTICALS INC earnings per share, diluted for the quarter ending 2016-09-30 was -$0.14.
- ARIAD PHARMACEUTICALS INC earnings per share, diluted for the quarter ending 2016-06-30 was $0.56.
- ARIAD PHARMACEUTICALS INC earnings per share, diluted for the quarter ending 2015-09-30 was -$0.29.
- ARIAD PHARMACEUTICALS INC earnings per share, diluted for the quarter ending 2015-06-30 was -$0.33.
- ARIAD PHARMACEUTICALS INC earnings per share, diluted for fiscal 2012 was -$1.34.
- ARIAD PHARMACEUTICALS INC earnings per share, diluted for fiscal 2011 was -$0.93, a 225.68% decline from fiscal 2010.
- ARIAD PHARMACEUTICALS INC earnings per share, diluted for fiscal 2010 was $0.74.
- ARIAD PHARMACEUTICALS INC earnings per share, diluted for fiscal 2009 was -$0.86.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2016-09-30 | -$0.14 10-Q · filed 2016-11-08 | $0.42 derived: net income ÷ weighted average shares · filed 2016-11-08 | $0.14 10-Q · filed 2016-11-08 | |
| 2016-06-30 | $0.56 10-Q · filed 2016-08-08 | $0.29 10-Q · filed 2016-08-08 | ||
| 2015-09-30 | -$0.29 10-Q · filed 2016-11-08 | -$0.63 derived: net income ÷ weighted average shares · filed 2016-11-08 | -$0.91 10-Q · filed 2016-11-08 | |
| 2015-06-30 | -$0.33 10-Q · filed 2016-08-08 | -$0.62 10-Q · filed 2016-08-08 | ||
| 2012-12-31 | -$0.36 derived: net income ÷ weighted average shares · filed 2015-03-02 | -$0.68 derived: net income ÷ weighted average shares · filed 2015-03-02 | -$1.34 10-K · filed 2013-03-01 | |
| 2012-09-30 | -$0.32 10-Q · filed 2012-11-09 | -$0.98 10-Q · filed 2012-11-09 | ||
| 2011-12-31 | -$0.38 derived: net income ÷ weighted average shares · filed 2014-03-03 | -$0.28 derived: net income ÷ weighted average shares · filed 2014-03-03 | -$0.63 derived: net income ÷ weighted average shares · filed 2014-03-03 | -$0.93 10-K · filed 2013-03-01 |
| 2011-09-30 | $0.10 10-Q · filed 2012-11-09 | -$0.25 derived: net income ÷ weighted average shares · filed 2012-11-09 | -$0.55 10-Q · filed 2012-11-09 | |
| 2011-06-30 | -$0.36 10-Q · filed 2011-08-09 | -$0.66 10-Q · filed 2011-08-09 | ||
| 2010-12-31 | -$0.24 derived: net income ÷ weighted average shares · filed 2013-03-01 | -$0.43 derived: net income ÷ weighted average shares · filed 2013-03-01 | $0.93 derived: net income ÷ weighted average shares · filed 2013-03-01 | $0.74 10-K · filed 2013-03-01 |
| 2010-09-30 | -$0.18 10-Q · filed 2011-11-07 | $1.22 derived: net income ÷ weighted average shares · filed 2011-11-07 | $1.04 10-Q · filed 2011-11-07 | |
| 2010-06-30 | $1.35 10-Q · filed 2011-08-09 | $1.22 10-Q · filed 2011-08-09 | ||
| 2009-12-31 | -$0.86 10-K/A · filed 2012-03-30 |